InsidersTradesSigma
Aarti Drugs Limited Stock: price and management transactions · India · SEBI (PIT + SAST)
Follow the Aarti Drugs Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are quoted on IN IN, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Aarti Drugs Limited has logged 67 insider filings. Market capitalisation: €31bn. The latest transaction was filed on 1 April 2022 (Purchase). Among the most active insiders: Safechem Enterprises Private Limited. The full history is openly available.
67
Insider Decl.
0
Thresholds
€2m
16 ops.
Buy Volume
€8m
51 ops.
Sell Volume
8Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 10,357 of 25,899 companies
57.2
score / 100
Value54
Quality61
FCF yld2.3%
Earn yld5.5%
EV/EBITDA13.2x
ROE13%
Gross mgn37%
Net mgn7.6%
Debt/EBITDA1.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 April 2022
Declarations67 total
50,000 shares@ ₹440.73322.0% of flowEquity SharesSEBI:772990de212fbe437710799e3934274cb217caf4
Ideal exit: 26 Dec 2022 (T+270)
53,500 shares@ ₹437.210834.9% of flowEquity SharesSEBI:7ebe6f289a05c28eb6e8501faf6fa394e23439f6
Ideal exit: 26 Dec 2022 (T+270)
25,000 shares@ ₹440.77939.3% of flowEquity SharesSEBI:747147572648e5e25866cf3fc68dd6efdb9fa581
Ideal exit: 26 Dec 2022 (T+270)
164,500 shares@ ₹438.130443.6% of flowEquity SharesSEBI:3a9fe497324dac3c2285044272b150405bdf912a
14,000 shares@ ₹440.780316.9% of flowEquity SharesSEBI:705cb443842637d2a2db1fe008dae568c5d04138
Ideal exit: 26 Dec 2022 (T+270)
11,000 shares@ ₹440.780213.3% of flowEquity SharesSEBI:4c7b82e7d5ad6bb2bba5c445d591797c0c9b31d6
Ideal exit: 26 Dec 2022 (T+270)
120,000 shares@ ₹440.536264.7% of flowEquity SharesSEBI:4cb306523b3cff167265c8eaccd8fb3d6fd2bf08
Ideal exit: 23 Dec 2022 (T+270)
70,000 shares@ ₹438.945746.0% of flowEquity SharesSEBI:4dd9d6ec3cd7435e359970ce740b30cd8c75106c
Ideal exit: 23 Dec 2022 (T+270)
180,615 shares@ ₹439.28248.2% of flowEquity SharesSEBI:9e317954615d4f72aad39c2c6b33b859a0370625
609 shares@ ₹459.35336.8% of flowEquity SharesSEBI:291c302e44702c60108378a3b14559eb6e4281b3
Ideal exit: 27 Nov 2022 (T+270)
500 shares@ ₹520.98223.7% of flowEquity SharesSEBI:628de7709512da35f476ccd9d68b904cdfbb417b
Ideal exit: 16 Sept 2022 (T+270)
20 shares@ ₹520.601.0% of flowEquity SharesSEBI:3206cff2e73608a9d0375a3fed090c3190f2a56c
Ideal exit: 21 Aug 2022 (T+270)
500 shares@ ₹459.70821.0% of flowEquity SharesSEBI:eed19423223a3c4a224e31e9f0dab6e1b1a38dc8
Ideal exit: 25 Nov 2022 (T+270)
500 shares@ ₹517.70623.6% of flowEquity SharesSEBI:a1d92dbd4a5f7f0bd032964a1312b71fbddf2ef0
Ideal exit: 28 Aug 2022 (T+270)
8,600 shares@ ₹503.07954.2% of flowEquity SharesSEBI:b00f8633b13ba29b8481f45487a317d3cfbf87e8
Ideal exit: 12 Nov 2022 (T+270)
10,000 shares@ ₹524.06265.2% of flowEquity SharesSEBI:3e15f0aadcb9df236aa025e38d215cf3f70ecc06
71,258 shares@ ₹524.543837.5% of flowEquity SharesSEBI:ff9bd60328c1d7a36c7c8315373282d9ca146315
13,120 shares@ ₹526.43486.9% of flowEquity SharesSEBI:d15ece23fe7275bb06d4145c4ad33b62f4bde008
8,705 shares@ ₹522.20644.5% of flowEquity SharesSEBI:be1f323b539b4719e2257bdf50cb32b5ca21cc5e
45,000 shares@ ₹523.128423.5% of flowEquity SharesSEBI:f86e303f1bce743f0148e37e7c58c9aecb569798
1,917 shares@ ₹522.91181.0% of flowEquity SharesSEBI:70713a810f0014cfb0ba8d519edd770551804385
200 shares@ ₹517.5750.1% of flowEquity SharesSEBI:3c10af7cc70cfd376b05420835f7e57129416b71
Ideal exit: 17 Sept 2022 (T+270)
10,741 shares@ ₹512.44265.4% of flowEquity SharesSEBI:280e403ce2e39363ac5a4224f3f94a251f92548c
Ideal exit: 28 Aug 2022 (T+270)
19,200 shares@ ₹519.54989.9% of flowEquity SharesSEBI:d97b94d555595295656c643f997bec9d945c325f
Ideal exit: 27 Aug 2022 (T+270)
19,647 shares@ ₹605.08811.7% of flowEquity SharesSEBI:25e8608ef38e5ffab2db757188b904240293fbc5
25 of 67 declarations
About Aarti Drugs Limited
Aarti Drugs Limited is an Indian company engaged in the manufacturing of pharmaceutical products. It is listed on the Bombay Stock Exchange.